Company page
Regentis Biomaterials Ltd.
Regentis Biomaterials Ltd. is a public company traded under the ticker RGNT in the American market. The company has a market capitalization of approximately $13.77 million. Regentis focuses on developing innovative biomaterials for medical applications.
- Ticker
- RGNT:AMEX
- Asset type
- Stock
- Market cap
- $13.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- AMEX
- Currency
- USD